Although we could not give the direct evidence for the role of IL12RB2 in our study, we could assume that IL12RB2, probably expressed on NK cells, enhanced anti-tumor immunity by increasing T or NK cell cytotoxicity and developing memory T cells under the condition of IL12 production. The gene discussed is IL12RB2; the disease is neoplasm.